PUMA BIOTECHNOLOGY, INC.: capex
| Value | {"amount": 132000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-06-30 |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:32.067047+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c8b9c6f2-3b39-43aa-b091-0d5ed5a2cf31
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-17-016942Retrieved: 2026-08-19T13:37:32.067047+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/capex/2017-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c8b9c6f2-3b39-43aa-b091-0d5ed5a2cf31
History
- no predecessors — first report